ArticleCase reports in hematology2026
Chylothorax as an Initial Presentation of Waldenström Macroglobulinemia: Report of Two Cases.
Article in Case reports in hematology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Chylothorax is an uncommon form of pleural effusion defined by the pathological accumulation of chyle within the pleural space. Although thoracic duct injury constitutes the most frequent cause, nontraumatic causes, including malignancies and lymphoproliferative disorders, merit consideration. Waldenström macroglobulinemia (WM), a lymphoplasmacytic lymphoma (LPL) characterized by bone marrow involvement and an immunoglobulin M (IgM) monoclonal gammopathy, rarely presents with pulmonary complications, and its association with chylothorax has been described in only a limited number of reports. Case Presentation: We describe two patients who presented with right-sided chylothorax as the initial manifestation of WM. Both patients underwent comprehensive diagnostic evaluation confirming LPL and received multimodal management comprising therapeutic pleural interventions and WM-directed systemic therapy. Conclusion: Chylothorax is a rare manifestation of WM and may represent the initial presentation of the disease. Early recognition, comprehensive diagnostic evaluation, and initiation of appropriate disease-directed therapy are essential for symptom control and management. Further studies are needed to better characterize the mechanisms, optimal treatment strategies, and long-term outcomes of WM-associated chylothorax.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.